Brief: Fusion Pharmaceuticals Announces IND Clearance For FPI-2068, A Jointly Developed Novel Targeted Alpha Therapy
12/04/2023 21:25
April 12 (Reuters) - AstraZeneca PLC AZN.L :
* FUSION PHARMACEUTICALS ANNOUNCES IND CLEARANCE FOR
FPI-2068, A
JOINTLY DEVELOPED NOVEL TARGETED ALPHA THERAPY
Source text for Eikon: ID:nCNW6WGfDa
Further company coverage: AZN.L
((Reuters.Brief@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary